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The mediodorsal prefrontal cortex (mdPFC) is a key structure of the central glucose-monitoring (GM) neural
network. Previous studies indicate that intracerebral streptozotocin (STZ) microinjection-induced destruction of local
chemosensory neurons results in feeding and metabolic alterations. The present experiments aimed to examine
whether STZ microinjection into the mdPFC causes metabolic deﬁcits. To do so, glucose tolerance test (GTT) and
measurements of plasma metabolites were performed in STZ-treated or control rats. Intraperitoneal D-glucose load
was delivered 20 min or 4 weeks following the intracerebral microinjection of STZ or saline (acute or subacute GTT,
respectively). The STZ-treated rats displayed acute glucose intolerance: at the 120th min of the test, blood glucose
level of these rats was signiﬁcantly higher than that of the ones in the control group. When determining the plasma
level of various metabolites, 30 min following the intracerebral STZ or saline microinjection, the triglyceride
concentration of the STZ-treated rats was found to be reduced compared with that of the control rats. The GM
neurons of the mdPFC are suggested to be involved in the organization of complex metabolic processes by which
these chemosensory cells contribute to adaptive control mechanisms of the maintenance of homeostasis.
Keywords: forebrain limbic circuitry, mediodorsal prefrontal cortex, glucose-monitoring neurons, STZ, glucose
intolerance, hypotriglyceridemia
Introduction
The prefrontal cortex (PFC) is implicated in various regulatory processes, including cognitive
functions, attention, working memory, drive and motivation, and organization of goal-
oriented behaviors like food and ﬂuid intake (5, 16, 17, 24). In addition to these already
known regulatory functions, the PFC was recently shown to play an important role in
glucoreception as well (27).
The homeostatically important process of glucoreception has been demonstrated
originally in some visceral organs, and later also in the peripheral, then, in the central
nervous systems (CNSs). By investigating the peripheral nervous system, Niijima (29)
observed that glucose injection of the portal vasculature reduced discharge frequency of
hepatic vagal ﬁbers in guinea pigs. A further step was the discovery of the existence of the so-
called glucose-monitoring (GM) neurons in the CNS (2, 31, 32). These cells detect changes in
the extracellular glucose concentration, in addition, they also utilize glucose as a signaling
modulator molecule to alter ﬁring rate. The GM neurons have to be distinguished from the
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glucose-insensitive cells that use the glucose only in their metabolism and do not show
activity changes to it at all (30).
The existence of neurons that are a part of the GM neural network has already been veriﬁed
in brain regions mutually interconnected with each other and the PFC, such as the lateral
hypothalamic area, ventromedial hypothalamic nucleus (VMH), amygdala, globus pallidus (GP),
nucleus accumbens, orbitofrontal (OBF) cortex, nucleus tractus solitarii, and in the area postrema
(AP) (1, 3, 11, 12, 14, 19, 34). The GM neurons have also been discovered in the mediodorsal
PFC (mdPFC) composed by neuroanatomical subdivisions of the PFC, such as the prelimbic and
cingulate cortices (27). GM neurons of the mdPFC possess special neurochemical responsive-
ness: their distinct dopamine and remarkable acetylcholine sensitivities are suggested to be of
distinguished signiﬁcance in the prefrontal cortical control of adaptive behaviors (26, 27).
Streptozotocin (STZ) – a chemical naturally produced by Streptomyces achromogenes –
is known to selectively destroy insulin producing β-cells of the pancreatic islets of Langerhans.
Correspondingly, it is widely used to induce experimental type 1 diabetes mellitus, creating an
effective animal model of the disease (8, 39). Therapeutic application of STZ is limited, due to
its severe side effects, to treating primary insulinomas. The STZ is similar enough to glucose to
be selectively transported into the cells by the type 2 glucose transporter protein (GLUT2), and
it has not been shown to be recognized by other type glucose transporters. After entering the
cell via GLUT2, STZ – among others – causes alkylation and consequent fragmentation of
DNA and its cytotoxic action includes reactive oxygen species mediated oxidative stress
mechanisms (39). The toxic effect of STZ is exerted not only in the pancreatic β-cells; it has
been reported that intracerebral microinjection of STZ decreases glucose utilization and
glycolytic processes of certain brain areas (6, 36). According to the previous ﬁndings of our
laboratory, similar intracerebral STZ microinjections destroy the GLUT2 positive chemosen-
sory (GM) neurons in various brain areas (e.g., VMH, OBF cortex, PFC, and GP) causing
severe deﬁcits of feeding and metabolism (7, 11–13, 15).
Despite the recent emerging of scarce and indirect data in the literature (23, 25, 28), little is
known yet about the involvement of prefrontal cortical neurons in the central metabolic control.
In the present experiments, therefore, to eliminate local chemosensory neurons, STZ
was microinjected bilaterally into the mdPFC of rats, and acute and subacute glucose
tolerance tests (GTTs) were performed as well as plasma metabolite levels determined to
elucidate metabolic signiﬁcance of chemosensory (GM) cells of the mdPFC.
Materials and Methods
Male Wistar rats (n= 97) with an average body weight of 270–340 g were housed individually
in a temperature and light controlled room (21± 2 °C; 12–12 h light–dark cycle) where
constant humidity (55%–60%) was assured. Tap water and laboratory chow food were ad
libitum available for the rats except where it is stated differently. The rats were divided into two
randomized and counterbalanced, evenly formed groups on the basis of their body weight. A
control GTT was performed before the experiments to select the unhealthy subjects. Twelve
rats (12.3% of all rats) with impaired glucose tolerance were excluded from the further analysis.
Anesthetized rats (n= 85, intraperitoneal ketamine, 50 mg/ml, 0.3 ml/100 g bw) were
operated on stereotaxically, their scalp was incised, and a small (4–5 mm in diameter) hole
was drilled through the cleaned skull. Guide cannulas made of 23 G stainless steel pipettes
were placed on the surface of the dura above the mdPFC by a mechanical microdrive
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(MN-33 Narishige, Japan). After positioning, the guide cannulas were ﬁxed to the cranium
using anchoring screws and dental acrylic.
Following a week-long recovery period, microinjection cannulas (30 G) were passed
through these guide cannulas to deliver the chemicals directly to the mdPFC. Stereotaxic
coordinates for mdPFC according to the stereotaxic rat brain atlas of Pellegrino et al. (35) were:
AP: +3.7 mm anterior to bregma (B), mediolateral (ML): 1 mm, and vertical (V): 1.5 mm from
dura (Fig. 1). Alert, previously well-handled rats were microinjected bilaterally with either
7.5 μg STZ (Sigma S-0130, 10 μg/μl; dissolved in sterile physiological saline) or sterile
physiological saline alone. Solutions were microinjected by a microinfusion pump (Cole
Parmer 789200C) in a volume of 0.75 μl for 1 min through a stainless steel microinjection
cannula extending 1.5 mm below the tips of the guide cannula ﬁxed on the skull with dental
acrylic. Microinjection cannulas were left in place for one more minute to help diffusion of
solutions into the target area.
The standardized GTT was performed after a 12 h food deprivation of the rats (n= 29).
Intraperitoneal injection of 20% D-glucose solution (0.2 g/100 g bw/ml) was administered at
the 20th min following the intracerebral microinjection of STZ or saline (acute GTT) and then
4 weeks later (subacute GTT). Blood samples were taken from the tail of rats and the
measurements were performed by glucometer (Glucometer Elite, Bayer, Germany).
In another animal group (n= 56), relevant plasma metabolites [total cholesterol, high-
density lipoprotein (HDL), triglycerides (TGs), and uric acid] were determined after a 12-h
food deprivation and 30 min after the bilateral STZ or saline microinjection by a semi-
automatic cold chemistry photometer (Spotchem EZ SP4430, Arkray, Japan).
After ﬁnishing all experiments, the rats were intraperitoneally overdosed with urethane
and transcardially perfused with physiological saline followed by 4% formalin. The brains
were ﬁxed in 4% formalin, then frozen and cut in 40 μm sections. Nissl (cresyl violet) staining
was used to examine and identify the exact site of microinjections. Rats with inappropriate
cannula positions (n= 4) were excluded from the further analysis.
In the GTT experiment, blood glucose levels of the animal groups were compared and
statistically analyzed. Similarly, statistical analysis was also performed for plasma metabo-
lites of rats of the STZ-treated and control groups. All results are reported as means± SEM.
Analysis of variance (one-way ANOVA) and Tukey’s test for post hoc comparisons were
used for statistical analysis. Differences were considered to be signiﬁcant at p< 0.05.
All experimental procedures were conducted in accordance with institutional, national,
and international regulations (BA02/2000-8/2012, Pécs University, Medical School; Law
XXVIII, 1998, Government Decree 40/2013, Hungary; NIH Guidelines 1997, European
Community Council Directive 86/609/EEC 1986, 2006; European Directive 2010/63/EU of
the European Parliament).
Results
GTT
Investigations of acute and subacute glucose tolerance after bilateral STZ or vehicle
microinjection into the mdPFC were performed in 29 adult male Wistar rats. Seventeen
rats were treated by STZ, whereas 12 control rats received physiological saline microinjec-
tion. The ﬁrst GTT was performed 20 min after the intracerebral microinjection (acute GTT),
whereas the second GTT was performed 4 weeks later (subacute GTT).
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Pathological alterations of blood glucose levels and a deﬁnite glucose intolerance of the
STZ-treated rats became obvious in the acute GTT. The ANOVA test showed a signiﬁcant
group difference in the acute GTT (F3, 57= 35.164; p< 0.05). The fasting blood glucose
levels were almost the same in the two groups (control: 4.84± 0.16 mmol/l and STZ: 4.81±
0.12 mmol/l, respectively). However, 2 h after the intraperitoneal glucose injection, blood
glucose level of the STZ-treated rats was signiﬁcantly higher than that of the rats in the
control group (control: 6.95± 0.14 mmol/l and STZ 8.6± 0.51; p< 0.05). The results are
shown in Fig. 2a.
Fig. 2. Impaired glucose tolerance in the acute GTT after bilateral streptozotocin (STZ) microinjection into the
mdPFC. (a) Fasting blood glucose levels of STZ-treated (n= 17) and control groups (n= 12) did not differ
signiﬁcantly. Two hours after the intraperitoneal glucose injection, however, blood glucose concentrations of the
STZ-treated rats signiﬁcantly increased compared with the control rats (*p< 0.05). Columns represent the
mean blood glucose levels± SEM. (b) Four weeks following the STZ or physiological saline microinjection
(subacute phase), the glucose tolerance was physiological in both groups: both the fasting and the 120th min’s blood
glucose levels of the rats were found to be in the similar range
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In the subacute phase, there was no signiﬁcant difference between the fasting blood
glucose concentrations of the STZ-treated and control groups (control: 4.74± 0.09 mmol/l
and STZ: 4.76± 0.12 mmol/l). Although the 120th min’s blood glucose levels appeared to be
higher in the rats subjected to STZ microinjection (control: 5.90± 0.21 mmol/l and STZ:
6.72± 0.18 mmol/l), there was no signiﬁcant difference between the two groups (Fig. 2b).
Plasma levels of metabolites
In a separate series of experiments with 52 adult male Wistar rats, 30 min after the bilateral
intracerebral microinjection into the mdPFC, plasma concentrations of total cholesterol, TG,
HDL, and uric acid were determined. Twenty-seven rats were treated by STZ-treated and 25
control rats received physiological saline microinjection. Plasma concentrations of total
cholesterol, HDL, and uric acid in the STZ-treated and control groups did not differ from each
other. At the same time, however, signiﬁcantly reduced plasma TG levels were detected in the
rats with mediodorsal prefrontal cortical STZ microinjection (control: 0.66± 0.03 mmol/l
and STZ: 0.56± 0.03 mmol/l, p< 0.05). The results are shown in Fig. 3.
Fig. 3. Plasma levels of metabolites of the STZ-treated (n= 27) and control (n= 25) rats 30 min following
the intracerebral microinjection. All results are reported as means± SEM. The plasma concentrations of
total cholesterol, HDL, and uric acid in the STZ-treated and control rats did not differ signiﬁcantly.
Signiﬁcant reduction of plasma TG levels was found, however, in the STZ microinjected group (*p< 0.05)
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Discussion
In the present study, evidence was obtained for the intimate involvement of mdPFC neurons
in the central regulation of metabolism. The results of our studies, ﬁrst time in the literature,
show that complex metabolic alterations develop as a consequence of bilateral mdPFC
microinjection of STZ. Selective destruction of the STZ sensitive neurons led to temporary
diabetes-like impaired glucose tolerance and altered TG level. The changes were character-
istically selective since other tested parameters (total cholesterol, HDL, and uric acid plasma
concentrations) and the subacute GTT did not show any signiﬁcant difference between the
STZ-treated and control rats.
In the healthy organism, the CNS takes part in the sophisticated control of metabolic
processes using integrating metabolic (degraded nutrients, fatty acids, amino acids, ketone
bodies, lactic acid, various metabolites, etc.), humoral–hormonal (e.g., insulin, leptin,
GLP-1, etc.), and complex neural information coming from the periphery as well as from
particular chemosensory neurons of various brain structures (12, 20, 33, 38). Since the
physiologically effective metabolism that maintains the balance of homeostasis among
broad environmental conditions is dependent upon central sensing of the relevant peripheral
signals, altered sensitivity of these special neurons may result in severe metabolic
disturbances that lead to such feeding-metabolic diseases as, e.g., obesity and diabetes
mellitus are (20).
Among patients with type 1 diabetes mellitus (T1DM), associations between meta-
bolic control measures and shrinkage of the prefrontal cortical thickness were found.
Patients with T1DM, relative to healthy control subjects, had thinner cortex in the
prefrontal cortical areas. Long-term glycemic control measures, expressed by the average
value of HbA1c, were found to be associated with bilateral thickness reduction in the
superior prefrontal cortical regions (21). The healthy human brain shows signiﬁcant levels
of hierarchical organization characterized by connections for top-down control with
minimum wiring cost (37). Relative absence of hierarchically high-level hubs in the PFC
of patients with T1DM was found, which suggests ineffective top-down control of the PFC
in T1DM (22). All these data substantiate the important role of PFC in the control of
carbohydrate metabolism.
Several data in the literature support the view that GLUT2, at least partially, is involved
in cerebral glucose sensing (4, 18). STZ, which at the periphery was shown to enter the β-cells
via GLUT2, has been demonstrated to also exert toxic effects in several brain regions.
Intracerebroventricular administration of STZ was observed to result in signiﬁcant reduction
of glucose utilization and glycolytic processes (6, 36). The toxic effect of STZ on certain
neurons, among others the GM ones, may get exerted via GLUT2 associated mechanisms. It
is important to mention, however, that an in vitro study raised doubts concerning the role of
GLUT2 in glucose sensing in the VMH, indicating a gatekeeper role of glucokinase in the
cerebral glucose sensing (10). Nevertheless, a previous study of ours revealed deﬁcits of
hypothalamic GLUT2 immunolabeling after STZ microinjection into the VMH of the rat
(40), and the present ﬁndings also support our hypothesis that the mdPFC neurons, among
them the local constituents of the limbic forebrain GM neural network, play an essential role
in the maintenance and preservation of the homeostatic balance.
One of our previous pilot studies showed that STZ treatment of the mdPFC caused
elevation of plasma concentration of insulin (unpublished observations), but it is evident that
further investigations are needed to conﬁrm these results. Damage to these chemosensory
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neurons appears to elicit and maintain complex feeding and metabolic disturbances. A single
bilateral microinjection of STZ into either the VMH or OBF cortex was found to cause
glucose intolerance and alterations of concentrations of plasma metabolites (12). STZ
microinjection into the VMH caused decreased total cholesterol and increased TG levels,
while STZ microinjection into the OBF resulted in signiﬁcant decrease of plasma total
cholesterol and TG levels. In the STZ-treated rats, in the present study, similar to the above
ﬁndings, the decrease of plasma TG concentrations was observed. Based on all these data, it
is reasonable to suppose that prefrontal cortical constituents of the forebrain GM network
participate in the central regulation of feeding and metabolism. It takes place supposedly
using complex control mechanisms, in part also determined by the existing multiple
functional morphological interrelationships of these structures. The signiﬁcance of these
data is further underlined by the results of recent experiments revealing that high-fat/
cholesterol diet increases plasma TG, total cholesterol, non-HDL, and HDL cholesterol
levels in rodents with a subsequent activation of cholinergic processes within the PFC, along
with cognitive impairments (23, 25), or by demonstrating the causal role of mdPFC D1
dopamine receptors in modifying high-fat food seeking (28). It is already a textbook material
that decreased TG can be due to hepatic failure, but our metabolic data – physiological level
of cholesterol and lactate dehydrogenase (LDH) – do not indicate liver failure. Instead, the
decrease of TG concentration may be considered as a consequence of complex regulatory
disturbance whose exact mechanism still remains to be revealed.
Feeding and metabolic disorders like obesity, diabetes mellitus, or metabolic
syndrome cause increasing burden on the modern societies. The presently used thera-
peutic approaches these days targeting the peripheral pathology so far could not fully
resolve the problems; consequently, at present, the above diseases cannot be cured yet. It
is reasonable to suppose that this is at least in part because dysfunction of the central
GM neurons is ignored in the evaluation of the above-mentioned illnesses. The physio-
logical functioning of these neurons appears to be indispensable with respect to the
maintenance of the homeostatic balance since these cells inﬂuence energy balance
regulation in a complex manner by simultaneously affecting multiple factors of homeo-
stasis, such as energy intake and energy expenditure, thermoregulation, and various other
factors as well (9).
Our present ﬁndings support the view that disturbance of the regulatory processes of the
CNS should necessarily to be taken into consideration in elucidating the background of the
above-mentioned diseases. With respect to this CNS involvement, the role of GM neurons
here appears to be especially important. They integrate complex chemical and other
information of various sources, which predestinate them to play signiﬁcant adaptive role
in the central regulation of feeding and metabolism.
Considering all of the above, we hope that the better understanding of complex
functional attributes of mdPFC chemosensory neurons and those of other brain structures
important in the maintenance of homeostasis can lead to the identiﬁcation of new drug targets
and the discovery of successful new therapeutic strategies as well.
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